Belotecan
Belotecan (CKD-602 free base) is a DNA topoisomerase I inhibitor. Belotecan induces cell apoptosis and cell-cycle arrest. Belotecan is a camptothecin analogue with anti-tumor effects, it can be used for the research of cancer[1].
Product Specifications
CAS Number
[256411-32-2]
Product Name Alternative
CKD-602 (free base)
UNSPSC
12352005
Hazard Statement
H301
Target
Apoptosis; Topoisomerase
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/belotecan.html
Purity
99.86
Solubility
DMSO : 12.5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C1[C@](O)(CC)C2=C(CO1)C(N3CC4=C(CCNC(C)C)C5=CC=CC=C5N=C4C3=C2)=O
Molecular Formula
C25H27N3O4
Molecular Weight
433.50
Precautions
H301
References & Citations
[1]Lee S, et al. CKD-602, a topoisomerase I inhibitor, induces apoptosis and cell-cycle arrest and inhibits invasion in cervical cancer. Mol Med. 2019 May 28;25 (1) :23.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
Launched
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
149203 50 µg
APP, Control Peptide (Amyloid beta A4 Protein, APP, ABPP, Alzheimer Disease Amyloid Protein, Cerebral Vascular Amyloid Peptide, CVAP, Protease Nexin-II, PN-II, APPI, PreA4, A4, AD1)
Ask
View Details GTR15275514 1 Vial
Lentiviral mouse Parl shRNA (UAS) - Lentiviral mouse Parl shRNA (UAS) (100)
Ask
View Details 
MBS6489009-01 0.1 mL
MEF2C, Phosphorylated (Thr20) (Myocyte-specific Enhancer Factor 2C) (MaxLight 650)
Ask
View Details MBS6489009-02 5x 0.1 mL
MEF2C, Phosphorylated (Thr20) (Myocyte-specific Enhancer Factor 2C) (MaxLight 650)
Ask
View Details